During the past decade, VieCuri Medisch Centrum conducted 82 clinical trials. In the 10-year time frame, 82 clinical trials started and 5 clinical trials were completed, i.e. on average, 6.1% percent of trials that started reached the finish line to date. In the past 5 years, 39 clinical trials started and 3 clinical trials were completed. i.e. 7.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "VieCuri Medisch Centrum" #1 sponsor was "Maastricht University Medical Center" with 11 trials, followed by "VieCuri Medical Centre" with 11 trials sponsored, "Radboud University Medical Center" with 8 trials sponsored, "The Netherlands Cancer Institute" with 8 trials sponsored and "Amgen" with 8 trials sponsored. Other sponsors include 63 different institutions and companies that sponsored additional 52 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "VieCuri Medisch Centrum" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 10 trials as a collaborator, "VieCuri Medical Centre" with 9 trials as a collaborator, "Borstkanker Onderzoek Groep" with 6 trials as a collaborator, "AstraZeneca" with 5 trials as a collaborator and "Maastricht University Medical Center" with 5 trials as a collaborator. Other collaborators include 182 different institutions and companies that were collaborators in the rest 157 trials.

According to Clinical.Site data, the most researched conditions in "VieCuri Medisch Centrum" are "Breast Cancer" (8 trials), "Colorectal Cancer" (7 trials), "Atrial Fibrillation" (5 trials), "Cardiovascular Disease" (4 trials) and "Chest Pain" (3 trials). Many other conditions were trialed in "VieCuri Medisch Centrum" in a lesser frequency.

Most popular intervention types in "VieCuri Medisch Centrum" are "Drug" (59 trials), "Other" (25 trials), "Device" (9 trials), "Procedure" (9 trials) and "Diagnostic Test" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Capecitabine" (4 trials), "Paclitaxel" (4 trials), "Bevacizumab" (3 trials) and "Carboplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "VieCuri Medisch Centrum" are 96 trials for "All" genders and 15 trials for "Female" genders.

Currently, there are NaN active trials in "VieCuri Medisch Centrum". undefined are not yet recruiting, 28 are recruiting, 15 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 46 completed trials in VieCuri Medisch Centrum, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in VieCuri Medisch Centrum, 0 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 25 trials that are defined as “Not Applicable".

VieCuri Medisch Centrum has several departments that took part in Clinical trials: "VieCurie Venlo, Cardiology" - 2 trials